CH

Cheil Worldwide Inc

Creates data-driven, integrated marketing and connected experiences for global brands.

030000 | KO

Overview

Corporate Details

ISIN(s):
KR7030000004
LEI:
Country:
South Korea
Address:
서울특별시 용산구 이태원로 222 제일기획, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cheil Worldwide Inc. is a global marketing and communications company, part of the Samsung Group. The firm specializes in creating integrated, data-driven marketing solutions focused on delivering "connected experiences" for brands. Its core services encompass advertising, public relations, brand strategy, digital marketing, retail and experiential design, and analytics. Cheil Worldwide develops 360-degree campaigns utilizing both traditional and emerging technologies, including AR, VR, and AI, to drive brand growth and commerce for a global client base. The company's offerings are structured around three main pillars: brand communications, experiential marketing, and commerce.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 18.9 KB
2025-09-01 00:00
Regulatory News Service
[기재정정]대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 23.1 KB
2025-08-29 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 45.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.7 MB
2025-08-13 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.6 KB
2025-08-04 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 42.5 KB
2025-07-25 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.3 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 5.6 KB
2025-07-04 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.9 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 90.7 KB
2025-06-04 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 37.5 KB
2025-06-02 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 219.0 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 888.8 KB
2025-05-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 39.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.5 MB

Automate Your Workflow. Get a real-time feed of all Cheil Worldwide Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cheil Worldwide Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cheil Worldwide Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.